Aldeyra Thinks It May Have Broadly Applicable Retinitis Pigmentosa Therapy

 
• By Joseph Haas
  
Genetic eye disease
Aldeyra's drug may address the underlying cause of retinitis pigmentosa • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D